BDBM50262509 1-(4-chloro-3-(trifluoromethyl)phenyl)-4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-yl)piperidine::CHEMBL478204
SMILES: Fc1ccc(-c2noc(n2)C2CCN(CC2)c2ccc(Cl)c(c2)C(F)(F)F)c(Cl)c1
InChI Key: InChIKey=ILTVKWITCXQNDJ-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50262509 (1-(4-chloro-3-(trifluoromethyl)phenyl)-4-(3-(2-chl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | n/a | n/a | 376 | n/a | n/a | n/a | n/a |
Amgen Inc. Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP binding | Bioorg Med Chem Lett 18: 4267-74 (2008) Article DOI: 10.1016/j.bmcl.2008.06.096 BindingDB Entry DOI: 10.7270/Q21C1WQ8 | |||||||||||
More data for this Ligand-Target Pair |